MedTrace Logo

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

NCT00053378 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2006-08-02

No results posted yet for this study

Summary

A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients

Conditions

Interventions

DRUG

paricalcitol injection (Zemplar)

BEHAVIORAL

Effects on calcium regulation

BEHAVIORAL

Administration of elemental Ca during hypocalcemic ICU pts.

Sponsors & Collaborators

Principal Investigators

  • Joel Z Melnick, M.D. · Abbott

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00053378 on ClinicalTrials.gov